Frontlight ResearchEarly access
Liver and biliary tract cancer trials in United States
302 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleDose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
- Where
- Palo Alto, Philadelphia
- Age
- 20 years to 99 years
- People
- 25
- Run by
- Teclison Ltd.
See details and how to joinNCT02174549 - No phaseTaking peopleMolecular Epidemiology of Biliary Tree Cancers
- Where
- Houston
- People
- 1,500
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT05179486 - Phase 2Taking peopleCombination of TATE and PD-1 Inhibitor in Liver Cancer
- Where
- Milwaukee, Oklahoma City, Orange
- Age
- 18 years to 80 years
- People
- 54
- Run by
- Teclison Ltd.
See details and how to joinNCT03259867 - Phase 2Taking peoplePatient Preference for Subcutaneous vs. Intravenous Immune Therapy
- Where
- Pittsburgh
- Age
- 18 years and over
- People
- 880
- Run by
- Diwakar Davar
See details and how to joinNCT07223424 - Phase 1/2Taking peopleA Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
- Where
- Aurora, Houston, Lake Mary, Lebanon, Providence
- Age
- 18 years and over
- People
- 126
- Run by
- 7 Hills Pharma, LLC
See details and how to joinNCT06362369 - Phase 1Taking peopleA Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-011 in Patients With Advanced Solid Tumor
- Where
- Houston, Jacksonville, New York, Phoenix, Rochester, Tampa
- Age
- 18 years to 75 years
- People
- 200 worldwide
- Run by
- Abbisko Therapeutics Co, Ltd
See details and how to joinNCT04906434 - Phase 2Not yet taking people in United StatesY-90 Radioembolization, Durvalumab, Tremelimumab, and Zanzalintinib for the Treatment of Unresectable and Locally-Advanced Hepatocellular Carcinoma
- Where
- Portland
- Age
- 18 years and over
- People
- 40
- Run by
- OHSU Knight Cancer Institute
See details and how to joinNCT07511504 - Phase 1Taking peopleEmavusertib (CA-4948) in Combination With Cisplatin, Gemcitabine, and Durvalumab in Patients With Untreated Advanced or Metastatic Biliary Tract Cancer
- Where
- St Louis
- Age
- 18 years and over
- People
- 48
- Run by
- Washington University School of Medicine
See details and how to joinNCT07107750 - Phase 2Taking peopleStudy of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC
- Where
- Baltimore, Beverly Hills, Buffalo, Germantown, Houston, Knoxville, La Jolla, Miami, Philadelphia, Pittsburgh, Tampa, The Bronx
- Age
- 18 years and over
- People
- 60
- Run by
- Replimune, Inc.
See details and how to joinNCT05733598 - Phase 1Taking peopleThis is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors
- Where
- Austin, TX 78758, Boston, San Antonio
- Age
- 18 years and over
- People
- 100
- Run by
- Zumutor Biologics Inc.
See details and how to joinNCT06451497 - Phase 2Taking peoplePh II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic CRC or HCC
- Where
- Tampa
- Age
- 18 years and over
- People
- 40
- Run by
- H. Lee Moffitt Cancer Center and Research Institute
See details and how to joinNCT06553885 - Phase 2Taking peopleIIT2025-03-YANG-LIFT-HCC
- Where
- Los Angeles
- Age
- 18 years and over
- People
- 41
- Run by
- Ju Dong Yang
See details and how to joinNCT07489976 - No phaseTaking peopleEvaluation of Resection Techniques for Pancreatic Tumors
- Where
- Dallas
- Age
- 18 years and over
- People
- 431
- Run by
- Methodist Health System
See details and how to joinNCT05128890 - No phaseTaking peopleLiver Transplantation in Intrahepatic Cholangiocarcinoma
- Where
- Newark
- Age
- 18 years to 89 years
- People
- 30
- Run by
- Rutgers, The State University of New Jersey
See details and how to joinNCT06140134 - No phaseTaking peopleRelapsed and Refractory Hepatoblastoma: A Prospective Registry and Liver Tumor Research Consortium Initiative
- Where
- Cincinnati
- People
- 500
- Run by
- Children's Hospital Medical Center, Cincinnati
See details and how to joinNCT05556642 - No phaseEnrolling by invitationLiquid Biopsy MonitORing Of CholangioCarcinOma for Treatment Response and Prognostic Outcomes (MOROCCO)
- Where
- Rochester
- Age
- 18 years and over
- People
- 100
- Run by
- Mayo Clinic
See details and how to joinNCT06474091 - Phase 1Taking peoplePhase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOY® (US-Sourced YERVOY®) As A First-Line Treatment For Patients With Unresectable Hepatocellular Carcinoma
- Where
- Brentwood, Glendale, Houston, Jacksonville, Margate, Olympia, Orange City, Plantation, Tacoma, Tamarac
- Age
- 18 years to 65 years
- People
- 246 worldwide
- Run by
- Shanghai Henlius Biotech
See details and how to joinNCT07176650 - No phaseTaking peopleFeasibility Study of CBCT for IGRT in Cancer Patients
- Where
- Columbus
- Age
- 18 years and over
- People
- 50
- Run by
- Varian, a Siemens Healthineers Company
See details and how to joinNCT06681233 - No phaseTaking peopleImmune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
- Where
- Jacksonville, Phoenix, Rochester
- Age
- 18 years and over
- People
- 324
- Run by
- Mayo Clinic
See details and how to joinNCT06349642 - No phaseTaking peopleThe MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
- Where
- Houston, Milwaukee, Pittsburgh
- Age
- 18 years and over
- People
- 8,000 worldwide
- Run by
- UMC Utrecht
See details and how to joinNCT04075305 - Phase 1Taking peopleStudy of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
- Where
- Aurora, Boston, Dallas, Huntersville, Layfayette, Madison, Nashville, New Brunswick, New York, Orange
- Age
- 18 years and over
- People
- 330 worldwide
- Run by
- I-Mab Biopharma US Limited
See details and how to joinNCT04900818 - Phase 2Taking peopleRiluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial
- Where
- Orange
- Age
- 18 years and over
- People
- 24
- Run by
- University of California, Irvine
See details and how to joinNCT07447050 - No phaseEnrolling by invitationActive Choice Clinical Decision Support (CDS): Hepatocellular Carcinoma (HCC) Screening in Patients With Cirrhosis
- Where
- New York
- Age
- 18 years and over
- People
- 1,300
- Run by
- NYU Langone Health
See details and how to joinNCT06624189 - Phase 2Taking peopleLigufalimab and Cadonilimab in Advanced Liver Cancers
- Where
- Dallas
- Age
- 18 years and over
- People
- 64
- Run by
- University of Texas Southwestern Medical Center
See details and how to joinNCT06789848 - Phase 2Taking peopleCheckpoint Inhibition In Pediatric Hepatocellular Carcinoma
- Where
- Boston, Cincinnati, Houston, San Francisco
- Age
- 0 years to 30 years
- People
- 18
- Run by
- Allison O'Neill, MD
See details and how to joinNCT04134559